About Geron Corporation
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Geron Corporation (GERN) Stock Score & Signals
Geron Corporation (GERN) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 47 out of 100.
2BB score and signals
Geron Corporation’s current 2BB score is 47 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 45 | Moderate |
| Momentum | 34 | Weakening |
| Financial strength | 37 | Weak |
| Quality | 100 | Very Strong |
| Risk | 43 | Moderate |
Company facts
| CEO | John A Scarlett |
| Headquarters | Menlo Park, California, United States |
| Founded | 1990 |
| Employees | 258 |
| 52-week range | $1.04 – $2.01 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-23 | — | -0.0027 | — | $67.70M |
| 2026-11-03 | — | -0.0073 | — | $61.91M |
| 2026-08-05 | — | -0.0092 | — | $56.31M |
| 2026-05-06 | -0.01 | -0.0211 | $51.84M | $51.59M |